Title of Invention

AN IMPROVED PROCESS FOR THE PREPARATION OF CHLORO METHYL CEPHEM DERIVATIVES

Abstract The present invention provides an improved process to produce the chloromethylcephem derivatives of the formula (I). wherein R<sub>1</sub> represents a carboxy-protecting group viz., substituted methyl group, which can be deprotected easily, such as t-butyl group, diphenylmethyl, 4- methoxybenzyl, 2-methoxybenzyl, 2-chlorobenzyl or benzyl group; R<sub>2</sub> represents hydrogen, (C<sub>1</sub>-C<sub>4</sub>)alkyl, substituted or unsubstituted phenyl or substituted or unsubstituted phenoxy group.
Full Text Field of the Invention
This patent application is filed as a "Patent of Addition" to our co-pending application number 808/MAS/2002, filed on November 01,2002.
The present invention provides an improved process to produce the chloromethvlceohem deR1vatives of the formula (W.
wherein R| represents a carboxyl-protecting group viz., substituted methyl group, which can be depredated easily, such as t-butyl group, diphenylmethyl, 4-methoxybenzyl, 2-methoxyben2yI, 2-chlorobenzyl or benzyl group; R2 represents hydrogen, (C1-C4)alkyl, substituted or unsubstantiated phenyl or substituted or unsubstantiated phoenix.
The chloromethylcephem deR1vatives of the formula (I) prepared according to the process of the present invention are useful for the preparation of cephalospoR1n antibiotics of the formula (11)

wherein R4 is carboxyl ate ion or COORd, where Rc represents hydrogen, esters or a counter ion which forms a salt; Rg represents H, CH3, CRaRbCO0Rc where R and Rb independently represent hydrogen or methyl and R" represents hydrogen or (C,-C6)alkyl; R5 represents CH3, CH2OCH3, CH2OCOCH3, CH-CH2, or


The cephalospoR1n antibiotics of the formula (II) have wide range of biological activity. SpeC1fically the cephalospoR1n antibiotics of the formula (II) have very good antibiotic activity.
Bacl^round of the Invention
In view of the importance of the S-chlq^omethylcephems of the formula (I), as key intermediates for the synthesis of a wide vaR1ety of cephalospoR1n drugs, vaR1ous methods of preparation were reported (US Patent 4,853,468; US Patent 4,789,740). In most of the cases, sulfonyl azetidinone deR1vatives of the formula (III) were subjected to allylic/ene-type chloR1nation with vaR1ous chloR1nating agents like chloR1ne, chloR1ne oxide, etc., to obtain the chloro azetidinone of the formula (IV). The chloro azetidinone compounds of the formula (IV) were further cyclized at low temperature in the presence of a base to get chloromethylcephems of the formula (I),


where R1 and R2 are as defined above; R3 represents phenyl, (C1-C4)alkylphenyi, (C|-C4)alkoxyphenyl or a heteroaryl group.
The preparation of sulfonyl azetidinone intermediate, as per the reported process, is always accompanied by the formation of a major impuR1ty, leading to low puR1ty of sulfonyl azetidinone, which in turn end up with low yield of the chloromethyl cephem of the formula (I).
In addition, the side product formed duR1ng the preparation of sulfonyl azetidinone intermediate could not be removed completely with the existing method of acetone/water system; and if this side product is not removed in this step, it leads to more impuR1ty formation duR1ng conversion to next step of chloR1nation & cyclization. Thus, there is a need to generate a process, which could take care of the removal of side product from sulfonyl azetidinone intermediate.
In addition, in the last step of cyclization with ammonia in DMF, we found that the impuR1ty formation is high duR1ng the addition of base. This necessitates the development of an alternative process, which would offer better conversion and consequently the yield.
With out continued search and intense investigation, we finally achieved identifying a clean process, which can address all the limitations discussed above, and produce the chloromethyl cephem deR1vatives of the formula (I).
Objectives of the Invention
The main objective of the present invention is to provide a simple and effiC1ent process for produC1ng chloromethyl cephem deR1vatives of the formula (I) through 3-chloromethyl azetidinone compounds of the formula (VII).
Another objective of the present invention is to provide a process for manufactuR1ng chloromethyl azetidinone compounds of the formula (Vll), without

employing the hazardous reagents, which are difficult-to-handle in manufacturing scales.
Another objective of the present invention is to canny out the preparation of the sulfonyl azetidinone in a clean manner, by controlling the formation of the major impurity & also provide a methodology to remove the side product.
Another objective of the present invention is to provide a process for cyclization of chloromethyl azetidinone compounds of the formula (VII) while minimizing the formation of the impurities and achieve maximum conversion.
Summary of the Invention
Accordingly, the present invention provides an improved process to produce the chlororaethylcephem derivatives of the formula (I)

wherein R1 represents a carboxy-protecting group viz., substituted methyl group,
which can be depredated easily, such as t-butyl group, diphenylmethyl, 4-
methoxybenzyl, 2-methoxybenzyl, 2-chlorobenzyl, or benzyl group; R2 represents
hydrogen, (Ci-C4)alkyl, substituted or unsubstantiated phenyl or substituted or
unsubstituted phenoxy, the said process comprising the steps of
(i) converting a compound of formula (V) to a compound of formula (VI)
where Rg represents substituted or unsubstituted (Ci-C6)alkyl or aryl group
using a metal salt of aryl sulfinic acid or (Ci-C6)alkyl sulfinic acid, a base
and a solvent at a temperature in the range of 25 °C to 40 °C, wherein the
improvement consists of adding the metal salt of aryl sulfinic acid in the pH
range of4 to 8.0,
(ii) chlorinating the compound of formula (VI) using chlorinating agent in the
presence of base and a solvent at a temperature in the range of 15 °C to 40

°C to produce a compound of formula (VII), where R8 represents
substituted or unsubstituted (C1-C6)alkyl or aryl group and all other
symbols are as defined above, and (vi). stylizing the compound of formula (VII) using a base in a solvent at a
temperature in the range of -60 °C to +50 °C to produce
chloromethylcephem derivatives of the formula (I).
The process of synthesizing chloromethyl cephem derivatives of the formula (I) is shown in Scheme I.
Scheme I

Description of the Invention
In an embodiment of the present invention the heteroaryl group represented by R7 is selected from 2-mercaptobenzothiazole, 2-mercaptobenzooxazole, 2-mercaptobenzimidazole or 2-mercapto-5-methyltetrazole.
In yet another embodiment of the present invention the conversion in step (i) is carried out using metal salt of aryl sulfmic aC1d selected from copper (II) p-toluenesulfmate, copper (II) benzenesulfmate, silver (II) p-toluenesulfinate, silver (II) benzenesulfinate and the like in the presence of a solvent selected from

acetone, THF, dioxin, diglyme, 2-butanone, acelonitrile, alcohols such as methanol, ethanol or iso-propanol, with or without water.
In yet another embidoment of the present invention, the step (i) is carried out while controlling the pH in the range 4-8, more preferably 5-7, by employing the base selected from ammonia, alkali/alkali earth metal carbonate/bicarbonate such as calcium carbonate, sodium bicarbonate, sodium carbonate, potassium carbonate, potassium hydrogen carbonate, or the organic bases such as diisopropylethylamine, triethylamine and the like.
In yet another embodiment of the present invention, chlorinating agent used in step (ii) is selected from chlorine gas, HOCl, CI2O, CH3OCI and the like in the presence of abase.
In yet another embodiment of the present invention, chlorinating agent used in step (ii) is either used as gas or a solution in a solvent selected from dioxane, carbon tetrachloride, ethyl acetate, acetonitrile, diglyme, dimethylformamide, dimethylacetamide, tetrahydrofuran, methylene chloride, butyl acetate, diphenyl ether, toluene, or mixtures thereof.
In yet another embodiment of the present invention, the base used in step (ii) is selected from alkali/alkali earth metal carbonate/bicarbonate such as calcium carbonate, sodium bicarbonate, sodium carbonate, potassium carbonate, potassium hydrogen carbonate and the like.
In yet another embodiment of the present invention the cyclization in step (iii) is carried out using a base selected from ammonia, ammonium salts like ammonium carbonate, ammonium acetate; organic amines like di-isopropylamine, ethylenediamine, diethylamine, methylamine, triethylamine and the like.
In yet another embodiment of the present invention, the cyclization step (iii) is carried out in a solvent selected from DMF, acetonitrile, dimethylacetamide, ethyl acetate, 4-formylmorpholine, 4-acetylmorpholine, dioxane, dimethylsulfoxide, THF, l-methylpyrrolidine-2-one (NMP), methylene dichloride and the like, or the mixtures thereof.

In another embodiment of the present invention the starting material can be prepared from the literature known in the prior art.
The foregoing technique has been found to be attractive from commercial, technological and ecological views, and affords chloromethyl azetidinone derivatives of the formula (VII).
Many other beneficial results can be obtained by applying disclosed invention in a different manner or by modifying the invention within the scope of disclosure.
The present invention is illustrated with the following examples, which should not be construed for limiting the scope of the invention.
Example 1:
Step ~1
Preparation of p-Methoxvbenzvl 2-f2-beiizothiazolyldithiD)-a-(l-
methvlethenvn-4-oxo-3-phenacetamido-l-azetidineacetatefV)
To dry toluene (500 ml) contained in a RB flask fitted with a Dean-Stark water separator, p-methoxybenzyl 6-phenacetamidopencilIanate-l-oxide (25 gm) and 2~ mercaptobenzothiazole (8.9 gm) were added at 27°C under nitrogen. The reaction mixture was heated under reflux over a period of 30 minutes and maintained at reflux temperature over 5 hours. After the reaction was over, the solvent was removed under vacuum to afford p-raethoxybenzyl 2-(2-benzothiazolyldithio)-a-(l-methyleth6nyl)-4-oxo-3-phenacetamido-l-azetidineacetate, which was taken to next step.
Step -2
Preparation of p-Methoxybenzyl 2-(p-toluenesulfonvlthiQ)-a-n-
methvlethenvl)-4-oxo-3-phenacetamidQ-l-azetidineacetate(VI)

To p-Methoxybenzyl 2-(2-faenzodiia2olyldithio)-a-(l-methylethenyI)-4-oxo-3-phenacetamido-l-azetidineacetate (obtained from 25 g of p-methoxybenzyl 6-phenacetamidopencillanate-1-oxide), acetone (220 mL) was added under stirring to get a clear solution at 28-30 °C & cooled to 20-25 °C. Water (32 mL) was added under stirring at this temperature. The pH of the solution was adjusted to 6.0-7.0 using saturated sodium bicarbonate solution. To the stirred solution, copper (II) p-toluenesulfmate (J3.0 g) was added over a period of 90-120 min at 20-25 "C in lots while maintaining the pH at 5.5-6.5 using saturated sodium bicarbonate solution. After the reaction was over, the reaction mixture was filtered through hyflo bed and the bed washed with acetone. The filtrate was concentrated under vacuum to remove the solvent in a rotary evaporator. To the residual mass, ethyl acetate (125 mL) and water (125 mL) were added, stirred for 5-10 min followed by sodium chloride addition. Organic layer was separated and washed two times with water. The organic layer was concentrated under vacuum at Step-3
Preparation of p-Methoxvbenzvl 2-(p-tolttenesttlfonvlthio-a-(l-
chloromethylethenvlV4-oxo-3-ph&nacetamido-l-azetidineacetatefVID
1,4-Dioxane (150 ml) was added to p-meihoxybenzyl 2-(p-toluenesulfonyIthio)-a-(l-methylethenyl)-4-oxo-3-phenacetamido-l-azetidineacetate (obtained fi-om 25.0 gm of p-methoxybenzyl 6-phenacetamidopenciIlanale-l-oxide as shown in step-2)

above followed by sodium bicarbonate (90 gm) at 26-28°C. CI2/CCI4 (12.5% w/v) (60 ml) added slowly. After the completion of the reaction, reaction mixture was filtered and washed with dichloromethane (150 ml). To the filtrate, cold water (450 mi) was added, organic layer separated, and washed with a solution of sodium thiosulphate followed by water. The organic layer was treated with charcoal, concentrated and worked up as usual to get p-methoxyfaenzyl 2-(p-toluenesulfonylthio)-a-(l-chloromethylethenyl)-4-oxo-3-phenacetamido-l-azetidineacetate, which was taken to next step without purification.
Step-4
Preparation of p-Methoxvbenzyl 7-phenylacetamido-3-chlQromethvl-3-
cephein-4-carboxvlate (I)
To p-methoxybenzyl 2-(p-toluenesuifonyIthio)-a-(l-chloromethylethenyl)-4-oxo-3-phenacetamido-l-azetidineacetate (obtained from 25.0 gm of p-methoxybenzyl 6-phenacetamido pencillanate-1-oxide), l-methylpyTrolidin-2-one (125 mL) was added at 28-30 °C and stirred to get a clear solution. To the solution, dichloromethane (50 mL) was added and cooled to -50 to -40 °C. To the reaction mixture, aqueous ammonia solution (25%, 8.8 mL) in l-methylpyrTolidin-2-one (25 mL, 2-5 °C) was added at -50 °C over a period of 2-5 min and the temperature was allowed to raise to ^0 °C. The reaction mixture was stirred at -45 to -40 °C for 15-20 min. To the reaction mixture, cold dil. HCI (1:1; 27 mL; 2-5 °C) was added at -50 to -40 °C in drops over a period of 5 min. The reaction mixture was poured into cold water (900 mL) at 2-5 °C. Dichloromethane was added, stirred for 5-10 min and the organic layer was separated. The aqueous layer was further extracted with dichloromethane. The organic layers were combined and washed with cold water four times at 5-10 °C. The solvent was removed completely under vacuum at
stirred at this temperature over 1 h, filtered and washed with cold methanol. The material thus obtained was dried under vacuum for 4-5 h to get p-methoxybenzyl 7-phenylacetamido-3-chloromethyl-3-cephem-4-carboxylate, as colorless solid. C15.1 gmV
Example 2:
Step-1
Preparation of D-Methoxvbenzvl 2-f2-benzotfaiazolvldithio)-a-(l-methvlethenvlM-oxo-3-pheiiacetamido-l-azetidineacetatefV)
To dry toluene (500 ml) contained in a RB flask fitted with a Dean-Stark water separator, p-methoxybenzyl 6-phenacetamidopencillanate-l-oxide (25 gm) and 2-mercaptobenzothiazole (8.9 gm) were added at 27°C under nitrogen. The reaction mixture was heated under reflux over a period of 30 minutes and maintained at reflux temperature over 5 hours (The reaction may also be carried out in dioxane as a solvent). After the reaction was over, the solvent was removed under vacuum to afford p-methoxybenzyl 2-(2-benzothiazolyldithio)-a-(l-methylethenyl)-4-oxo-3-phenacetamido-l-azetidineacetate, which was taken to next step.
Step -2
Preparation of p-Methoxvbenzvl 2-(p-toluenesutfonvlthioVa-(l-
methvlethenvl)-4-oxo-3-phenacetamido-l-azetidineacetate
To p-Methoxybenzyl 2-(2-benzothiazolyldithio)-a-(l-methylethenyl)-4-oxo-3-phenacetamido-1-azetidineacetate (obtained from 25 g of p-methoxybenzyl 6-phenacetamidopencillanate-1-oxide), acetone (220 mL) was added under stirring to get a clear solution at 28-30 °C & cooled to 20-25 °C. Water (32 mL) was added under stirring at this temperature. The pH of the solution was adjusted to 6.0-7.0 using saturated sodium bicarbonate solution. To the stirred solution, copper (II) p-toluenesulfmate (13.0 g) was added over a period of 90-120 min at

20-25 °C in lots while maintaining the pH at 5.5-6.5 using saturated sodium bicarbonate solution. After the reaction was over, the reaction mixture was filtered through hyflo bed and the bed washed with acetone. The filtrate was concentrated under vacuum to remove the solvent in a rotary evaporator. To the residual mass, ethyl acetate (125 mL) and water (125 mL) were added, stirred for S-10 min followed by sodium chloride addition. Organic layer was separated and washed two times with water. The organic layer was concentrated under vacuum at Step-3
Preparation of p-Methoxybenzyl 2-(p-toluenesuifonvlthio)-a-(l-
chlorQmethylethenvn-4-oxo-3-phenacetainido-l-azetidineacetate
1,4-Dioxane (150 ml) was added to p-methoxybenzyl 2-(p-toluenesulfonylthio)-a-(l-methylethenyl)-4-oxo-3-phenacetamido-l-azetidineacetate (obtained from 25.0 gm of p-methoxybenzyl 6-phenacetamidopencillanate-l-oxide as shown in step-2) above followed by sodium bicarbonate (90 gm) at 26-28""C. CI2/CCI4 (12.5% w/v) (60 ml) added slowly. After the completion of the reaction, reaction mixture was filtered and washed with dichloromethane (150 ml). To the filtrate, cold water (450 ml) was added, organic layer separated, and washed with a solution of sodium thiosulphate followed by water. The organic layer was concentrated and worked up as usual to get p-methoxybenzyl 2-(p"toluenesulfonylthio)-a-(l-

chloromethyIethenyl)-4-oxo-3-phenacetamido-l-azetidineacetate, which was taken to next step without purification.
Step-4
Preparation of p-Methoxybenzvl 7-phenvlacetamido-3-chloromethvl-3-
cepheni-4-carboxylate
p-Methoxybenzyl 2-(2-toluenesulfonylthio)-a-(l-chloromethylethenyl)-4-oxo-3-phenacetamido-1-azetidineacetate (obtained from 25.0 gm of p-methoxybenzyl 6-phenacetamido pencillanate-1-oxide), obtained according to step-3 of example-1 above, was added to OMF (125 ml) and cooled to —40 °C A solution of ammonia (11.5 ml) in DMF was added and maintained at the same temperature until the reaction was completed. The reaction mixture was acidified with dil. HCl, filtered. The soHd obtained was extracted with DMF: methanol (2:9) with charcoal, concentrated and treated with cold methanol to get p-methoxybenzyl 7-phenac6tamido-3-chloromethyl-3-cephem-4-carboxylate. (13.6 gm).
Reference Example 3:
Step -1
Preparation of p-Methoxybenzyl 2-("2-benzQthiazolvldithioVct-(l-
methvlethenvl)-4-oxQ-3-phenacetamidQ-l-azetidineacetatefV)
To dry toluene (500 ml) contained in a RB flask fitted with a Dean-Stark water separator, p-methoxybenzyl 6-phenacetamidopencillanate-l-oxide (25 gm) and 2-mercaptobenzothiazole (8.9 gm) were added at 27""C under nitrogen. The reaction mixture was heated under reflux over a period of 30 minutes and maintained at reflux temperature over 5 hours (The reaction may also be carried out in dioxane as a solvent). After the reaction was over, the solvent was removed under vacuum to afford p-methoxybenzyl 2-(2-benzothiazolyldithio)-a-(l-methylethenyI)-4-oxo-3-phenacetamido-l-azetidineacetate, which was taken to next step.

step "2
Preparation of p-Methoxybenzvl 2-(p-toluenesulfonyIthio)-a-fl-
niethvlethenvl)-4-oxQ-3-phenacetamido-l-azetidineacetate (Vl)
To p-Methoxybenzyl 2-(2-benzothiazolyldithio)-a-(l-methylethenyI)-4-oxo-3-phenacetamido-1-azetidineacetate (obtained from 25 g of p-methoxybenzyl 6-phenacetamidopencillanate-1-oxide), acetone {220 mL) was added under stirring to get a clear solution at 28-30 °C & cooled to 20-25 °C. Water (32 mL) was added under stirring at this temperature. To the stirred solution, copper (II) p-toluenesulfinate (12.8 g) was added over a period of 90-120 min at 20-25 °C in lots. After the reaction was over, the reaction mixture was filtered through hyflo bed and the bed washed with acetone. The filtrate was concentrated under vacuum to remove the solvent in a rotary evaporator. To the residual mass, ethyl acetate (125 mL) and water (125 mL) were added, stirred for 5-10 min followed by sodium chloride addition. Organic layer was separated and washed two times with water. The organic layer was concentrated under vacuum at Step -3
Preparation of p-Methoxvbenzvl 2-fp-toluenesulfonvlthio)-a-(l-
chloromethvlethenvn-4-Qxo-3-phenacetainido-l-azetidineacetate(VIl)
1,4-Dioxane (150 ml) was added to p-methoxybenzyl 2-(p-toluenesulfonylthio)-a-(l-methylethenyl)-4-oxo-3-phenacetamido-l-azetidineacetate (obtained from 25.0 gm of p-methoxybenzyl 6-phenacetamidopencillanate-l-oxide as shown in step-2)

above followed by sodium bicarbonate (90 gm) at 26-28°C. CI2/CCI4 (12.5% w/v) (60 ml) added slowly. After the completion of the reaction, reaction mixture was filtered and washed with dichloromethane (150 ml). To the filtrate, cold water (450 ml) was added, organic layer separated, and washed with a solution of sodium thiosulphate followed by water. The organic layer was treated with charcoal, concentrated and worked up as usual to get p-methoxybenzyl 2-(p-to!uenesulfonylthio)-a-( 1 -chloromethylethenyl)-4-oxo-3-phenacetamido-1 -azetidineacetate, which was taken to next step without purification.
Step^
Preparation of p-methoxybenzyl 7-phenacetamido-3-chloromethvl-3-cephem-
4-carboxylate
p-Methoxybenzyl 2-(2-toluenesulfonylthio)-a-(l-chloromethylethenyl)-4-oxo-3-phenacetaraido-1-azetidineacetate (obtained fi-om 25.0 gm of p-methoxybenzyl 6-phenacetamido pencillanate-1 -oxide), obtained according to step-3 of example-1 above, was added to DMF (125 ml) and cooled to -40 °C. A solution of ammonia (11.5 ml) in DMF was added and maintained at the same temperature until the reaction was completed. The reaction mixture was acidified with dil. HCl, filtered. The solid obtained was extracted with DMF: methanol (2:9) with charcoal, concentrated and treated with cold methanol to get p-methoxybenzyl 7-phenacetamido-3-chloromethyl-3-cephem-4-carboxylate. (11.4 gm)


From the table it can be concluded,
> pH adjustment during step (ii) increases the purity of 2-(p-
toluenesulfonylthio)-a-( 1 -methylethenyl)-4-oxo-3-phenacetamido-1 -
azetidineacetate.
> The use of NMP at cyclization step gives more yields when compared to
DMF.

We Claim:
1. An improved process to produce the chloromethylcephem derivatives of the formula (I)
wherein R| represents a carboxy-protecting group viz., substituted methyl group, which can be deprotected easily, such as t-butyl group, diphenylmethyl, 4-methoxybenzyl, 2-methoxybenzyl, 2-chlorobenzyl or benzyl group; R2 represents hydrogen, (C|-C4)alkyl, substituted or unsubstituted phenyl or substituted or unsubstituted ohenoxv. the said orocess comDrisine the steos of
where R8 represents substituted or unsubstituted (C1-C6)alkyl or aryl group using a metal salt of aryl sulfinic aC1d or (C1-C6)alkyl sulfinic aC1d, a base and a solvent at a temperature in the range of 25 °C to 40 °C, wherein the improvement consists of adding the metal salt of aryl sulfinic aC1d in the pH range of 4.0 to 8.0,

(ii) chlorinating the compound of formula (VI) using chlorinating agent in the presence of base and a solvent at a temperature in the range of 15°C to 40 °C to produce a compound of formula (VII),

where Rg represents substituted or unsubstituted (C1-C6)alkyl or aryl group and all other symbols are as defined above, and
(iii) cyclizing the compound of formula (VII) using a base in a solvent at a temperature in the range of -60 °C to +50 °C to produce chloromethylcephem derivatives of the formula (I).
2. The process according to claim 1, wherein the metal salt of aryl sulfinic aC1d used in step (i) is selected from copper (II) p-toluenesulfinate, copper (II) benzenesulfinate, sodium toluenesulfinate, silver (II) p-toluenesulfmate or silver (II) benzenesulfinate.
3. The process according to claim 1, wherein the solvent used in step (i) is selected from acetone, THF, dioxane, acetonitrile, alcohols such as methanol, ethanol or isopropanol, with or without water.
4. The process according to claim 1, wherein the addition of metal salt of aryl sulfinic aC1d or (C1-C6)alkyl sulfmic aC1d in step (i) is carried out preferably in the pH range of 5-7.
5. The process according to claim 1, wherein the base used in step (i) is selected from ammonia, calC1um carbonate, sodium bicarbonate, sodium carbonate, potassium carbonate, potassium hydrogen carbonate, diisopropylethylamine, or triethylamine.
6. The process according to claim 1, wherein the chlorinating agent used in step (ii) is selected from chlorine gas, HOCl, C12O or CH3OC1 in the presence or absence of a solvent.

7. The process according to claim 5, wherein chlorinating agent is dissolved in dioxane, carbon tetrachloride, ethyl acetate, acetonitrile, diglyme, dimethylformamide, dimethylacetamide, tetrahydrofuran, methylene chloride, butyl acetate, diphenyl ether, toluene, or mixtures thereof.
8. The process according to claim 1, wherein the solvent used in step (ii) is selected from dioxane, carbon tetrachloride, ethyl acetate, acetonitrile, diglyme, dimethylformamide, dimethylacetamide, tetrahydrofuran, methylene chloride, butyl acetate, diphenyl ether, toluene, or mixtures thereof.
9. The process according to claim 1, wherein the cyclization in step (iii) is carried out using a base selected from ammonia, ammonium salts like ammonium carbonate, ammonium acetate; organic amines like N,N-diisopropylamine, N,N-diethylamine, methylamine ortriethylamine..
10. The process according to claim 1, wherein the solvent used in step (iii) is selected from l-methylpyrrolidine-2-one (NMP), DMF, acetonitrile, N,N-dimethylacetamide, ethyl acetate, dioxane, THF, methylene dichloride.
11. The process according to claim 1, further comprising converting the compound of formula (I) into compound of formula (II).
OR.

wherein R4 is carboxylate ion or COORd, where Rj represents hydrogen, esters or a counter ion which forms a salt; Rf, represents H, CH3, CRaRbCOORc where Ra and Rb independently represent hydrogen or methyl and Rc represents hydrogen or (Ci-C6)alkyl; R5 represents CH3, CH2OCH3, CH2OCOCH3, CH=CH2, or

Documents:

0846-che-2003 abstract-duplicate.pdf

0846-che-2003 abstract.jpg

0846-che-2003 abstract.pdf

0846-che-2003 claims-duplicate.pdf

0846-che-2003 claims.pdf

0846-che-2003 correspondence-others.pdf

0846-che-2003 correspondence-po.pdf

0846-che-2003 description (complete)-duplicate.pdf

0846-che-2003 description (complete).pdf

0846-che-2003 form-1.pdf

0846-che-2003 form-19.pdf

0846-che-2003 form-5.pdf

0846-che-2003 pct-search report.pdf

0846-che-2003 pct.pdf


Patent Number 218398
Indian Patent Application Number 846/CHE/2003
PG Journal Number 21/2008
Publication Date 23-May-2008
Grant Date 01-Apr-2008
Date of Filing 21-Oct-2003
Name of Patentee ORCHID CHEMICALS & PHARMACEUTICALS LTD.
Applicant Address ORCHID TOWERS, 313, VALLUVAR KOTTAM HIGH ROAD, NUNGAMBAKKAM, CHENNAI 600 034,
Inventors:
# Inventor's Name Inventor's Address
1 UDAYAMPALAYAM PALANISAMY SENTHILKUMAR N. UDAYAMPALAYAM, POST. KULLAMPALAM, Tq. GOBICHETTIPALAYAM, ERODE 638 476,
2 PADMANABHAN RAMAR 9/26-B, B.S.R.. STREET, SIVAGIRI, THIRUNELVELLI,
3 SANJAY NIVRUTTI KARALE C/O. LAXMI NIVAS, URBAN BANK, COLONY VEER SAVARKAR MARG, AHMEDNAGAR 414001,
4 PANDURANG BALWANT DESHPANDE C-1 CEEBROS, PLOT NO. 32 (NEW) 1ST AVENUE, INDIRA NAGAR, CHENNAI 600 020,
PCT International Classification Number CO7D 501/02
PCT International Application Number N/A
PCT International Filing date
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 NA